Prequalification Update - 03 February 2012

WHO Prequalification Programme publishes new WHO Public Assessment Reports (WHOPARs)

     The WHOPARs cover the following products:

• HA471:     Didanosine - 125mg - Capsules - Mylan Laboratories Ltd - INDIA

• HA472:     Didanosine - 200mg - Capsules - Mylan Laboratories Ltd - INDIA

• HA473:     Didanosine - 250mg - Capsules - Mylan Laboratories Ltd - INDIA

• HA474:     Didanosine - 400mg - Capsules - Mylan Laboratories Ltd - INDIA  

• MA069:     Artemether/Lumefantrine - 20mg/120mg - Tablets - Novartis Pharmaceuticals Corporation - USA

Related Link:  Overview of WHOPARs of Prequalified Medicinal Products